רופילק 300

Страна: Израел

Език: иврит

Източник: Ministry of Health

Активна съставка:

ANTI-D IMMUNOGLOBULINS

Предлага се от:

CSL BEHRING LTD., ISRAEL

АТС код:

J06BB01

Лекарствена форма:

תמיסה להזרקה

Композиция:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Начин на приложение:

תוך-שרירי, תוך-ורידי

Вид предписание :

מרשם נדרש

Произведено от:

CSL BEHRING AG, SWITZERLAND

Терапевтична група:

ANTI-D (RH) IMMUNOGLOBULIN

Терапевтична област:

ANTI-D (RH) IMMUNOGLOBULIN

Терапевтични показания:

Prophylaxis of Rh (D) immunisation in Rh (D)-negative women: Anti-D immune globulin is administered for the prevention of Rh (D) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. Treatment is not necessary when it is assured that the child or the father are Rh (D)- negative. Criteria for a rhesus-incompatible pregnancy and the administration of anti-D immune globulin are : a) the mother is Rh (D) -negative b) the child is either Rh (D)-positive Rh (D)weak - positive or its rhesus type is not known. Routine antepartum prophylaxis : To prevent Rh (D) immunisation due to spontaneous fetomaternal haemorrhage (FMH) during the last trimester of pregnancy. Postpartum prophylaxis To prevent Rh (D) immunisation of the Rh (D)-negative mother following delivery of a Rh (D)-positive child. Complications of pregnancy: Interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood s

Дата Оторизация:

2023-02-28